pharmaceutical investing Dermira’s Share Price Takes a Hit as Two Clinical Trials Failed to Meet Co-Primary Endpoints
medical device investing HTG Molecular Diagnostics Announces Completion of Public Offering of Common Stock
Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys
Fortune Minerals Announces Additional Government Support to Help Purchase the NICO Alberta Refinery Site